Dr. Jim Flatt brings over three decades of leadership in the biotechnology and renewable products industries to DMC Biotechnologies. With a Ph.D. in Chemical Engineering from the University of Wisconsin and advanced degrees from UC Berkeley and MIT, Jim has a proven track record of innovation in commercial bioactive compounds, precision fermentation, and sustainable bioproduct solutions. Prior to DMC, Jim co-founded Brightseed, where he pioneered AI-driven health ingredient discovery and led the company to early commercial success, securing over $125M in funding and developing a number of partnerships with industry leaders as CEO. His leadership spans roles at Synthetic Genomics, Martek Biosciences, and Monsanto, where he successfully scaled and commercialized novel technologies. Jim's expertise in biotechnology, product development, and strategic growth positions him to lead DMC into its next phase of impactful innovation and commercialization of its pipeline products.